Switch to:
More From Other Websites
​Tiny Waltham biotech's market cap doubles after $103M Valeant licensing deal Feb 21 2017
Valeant Acquires Eyegate Licensing Rights Feb 21 2017
Tuesday’s Top Biopharma Movers Feb 21 2017
The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan,... Feb 21 2017
EyeGate Pharma surges 15% on news of Valeant licensing agreement Feb 21 2017
EyeGate Pharma surges 15% on news of Valeant licensing agreement Feb 21 2017
Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product... Feb 21 2017
Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product... Feb 21 2017
This Guru Loves Valeant; Should You? Feb 20 2017
[$$] Unilever was a deal too far for Kraft Heinz Feb 20 2017
Sequoia's Foundation Looks Stronger Than It Was Before Feb 19 2017
Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S. Feb 17 2017
AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial Feb 17 2017
Francis Chou Adds to Valeant, Trims Sears in 4th Quarter Feb 16 2017
Billionaire Bill Ackman’s Pershing Square Boosts Bet on Fast Food Industry, Cuts Down on... Feb 16 2017
Why This FDA Approval for Valeant Is Not as Good as First Thought Feb 16 2017
New Valeant Approval is a Surprise Irritant Feb 16 2017
Valeant Pharmaceuticals: Dead in the Water? Feb 16 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK